Pharmaceutical and biotech sector sees net outflow of 10.9 billion yuan, led by WuXi AppTec and Hengrui Medicine

Industry
โดย 证券时报·Read original
Summary · why it matters

On July 17, the pharmaceutical and biotech sector fell 5.89%, with full-day net outflow of main funds reaching 10.914 billion yuan. Among the 477 stocks in the sector, 21 saw net outflows exceeding 100 million yuan. WuXi AppTec recorded a net outflow of 944 million yuan, Hengrui Medicine 810 million yuan, and Harbin Pharmaceutical Group 626 million yuan, topping the list. On the inflow side, Andon Health led with a net inflow of 582 million yuan, while Fushine Pharmaceutical and Dizal Pharmaceutical recorded net inflows of 73.1845 million yuan and 65.0959 million yuan respectively. Main funds across both exchanges saw a full-day net outflow of 138.097 billion yuan, with only the utilities sector attracting a net inflow of 642 million yuan.

Impact on stocks 17

© 2026 MarketDXNews